AML/MDS Clinical Trials

7 clinical trials for AML/MDS across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) — RECRUITING · PHASE1
• Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML — RECRUITING · PHASE1
• Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial — RECRUITING · PHASE2
• SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS — ACTIVE_NOT_RECRUITING · PHASE1
• Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML — COMPLETED · PHASE1
• Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients — ACTIVE_NOT_RECRUITING · PHASE2
• Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT — TERMINATED · PHASE1

Refine this search